Total Payments
$1.9M
2024 Payments
$1.9M
Companies
7
Transactions
11
Medicare Patients
14,376
Medicare Billing
$7.1M
Payment Breakdown by Category
Other$1.9M (100.0%)
Food & Beverage$313.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $1.9M | 2 | 100.0% |
| Food and Beverage | $313.89 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $1.9M | 2 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $187.08 | 4 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $46.29 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.91 | 1 | $0 (2018) |
| Medtronic, Inc. | $19.83 | 1 | $0 (2021) |
| ARGON MEDICAL DEVICES, INC. | $17.00 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $16.78 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1.9M | 3 | Stryker Corporation ($1.9M) |
| 2021 | $66.12 | 2 | BOSTON SCIENTIFIC CORPORATION ($46.29) |
| 2020 | $187.08 | 4 | Bard Peripheral Vascular, Inc. ($187.08) |
| 2019 | $16.78 | 1 | Merck Sharp & Dohme Corporation ($16.78) |
| 2018 | $26.91 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26.91) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Stryker Corporation | — | Acquisitions | Cash or cash equivalent | $1,394,130.21 | General |
| 09/19/2024 | Stryker Corporation | — | Acquisitions | Cash or cash equivalent | $534,530.33 | General |
| 07/26/2024 | ARGON MEDICAL DEVICES, INC. | Clot Management (Device) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: VASCULAR | ||||||
| 12/16/2021 | Medtronic, Inc. | Chameleon (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Percutaneous Transluminal Angioplasty (PTA) Balloons | ||||||
| 10/19/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ULTRASOUND (Device) | Food and Beverage | In-kind items and services | $46.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/26/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 08/20/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 08/13/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $62.51 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 07/29/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $71.58 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 04/04/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), VAQTA, GARDASIL9 | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: VACCINE | ||||||
| 06/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,440 | 9,373 | $7.4M | $1.7M |
| 2022 | 31 | 4,323 | 12,229 | $8.9M | $2.2M |
| 2021 | 32 | 2,903 | 5,404 | $4.3M | $1.1M |
| 2020 | 34 | 3,710 | 7,748 | $7.5M | $2.0M |
Total Patients
14,376
Total Services
34,754
Medicare Billing
$7.1M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 75898 | Imaging of blood vessel | Office | 2022 | 69 | 75 | $49,550 | $9,987 | 20.2% |
| 36589 | Removal of tunneled central venous tube | Office | 2022 | 60 | 61 | $57,950 | $9,402 | 16.2% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Office | 2022 | 82 | 96 | $43,200 | $9,031 | 20.9% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2022 | 297 | 537 | $80,550 | $6,184 | 7.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 71 | 87 | $15,225 | $5,416 | 35.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 22 | 22 | $18,700 | $4,127 | 22.1% |
| J2997 | Injection, alteplase recombinant, 1 mg | Office | 2022 | 13 | 38 | $5,700 | $2,590 | 45.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Office | 2022 | 45 | 49 | $17,150 | $1,807 | 10.5% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 12 | 12 | $6,250 | $1,453 | 23.3% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 76 | 89 | $8,900 | $1,096 | 12.3% |
| 36593 | Declotting of central venous tube | Office | 2022 | 13 | 20 | $5,000 | $662.46 | 13.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 69 | 4,000 | $5,000 | $412.16 | 8.2% |
| 36902 | Insertion of needle and/or catheter into dialysis circuit and balloon dilation of dialysis segment, with imaging including radiological supervision and interpretation | Office | 2021 | 272 | 348 | $1.5M | $449,875 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 476 | 812 | $203,275 | $71,596 | 35.2% |
| 37246 | Balloon dilation of artery, accessed through the skin or by open procedure, with imaging including radiological supervision and interpretation, initial artery | Office | 2021 | 29 | 30 | $195,000 | $59,674 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 316 | 462 | $184,800 | $57,592 | 31.2% |
| 36907 | Balloon dilation of dialysis segment, accessed through the skin, with imaging including radiological supervision and interpretation | Office | 2021 | 68 | 83 | $186,750 | $56,502 | 30.3% |
| 36012 | Insertion of catheter into vein, second order branch | Office | 2021 | 94 | 118 | $354,000 | $54,088 | 15.3% |
| 93990 | Ultrasound of dialysis access | Office | 2021 | 316 | 407 | $345,950 | $53,028 | 15.3% |
| 36215 | Insertion of catheter into chest or arm artery, each first order branch | Office | 2021 | 74 | 85 | $181,000 | $50,630 | 28.0% |
| 36821 | Relocation of arm vein with connection to arm artery, open procedure, any site as separate procedure | Facility | 2021 | 58 | 60 | $210,000 | $43,355 | 20.6% |
| 36905 | Excision of blood clot and/or infusion to dissolve blood clot in dialysis circuit and balloon dilation of dialysis segment, , accessed through the skin, with imaging including radiological supervision and interpretation, with balloon catheter | Office | 2021 | 12 | 17 | $140,250 | $42,738 | 30.5% |
| 36901 | Insertion of needle and/or catheter into dialysis circuit, with imaging including radiological supervision and interpretation | Office | 2021 | 39 | 42 | $88,200 | $22,033 | 25.0% |
| 35011 | Repair of diseased or bulging (aneurysm) artery of arm | Facility | 2021 | 18 | 19 | $76,000 | $20,895 | 27.5% |
| 75710 | Radiological supervision and interpretation of imaging of artery of one arm or leg | Office | 2021 | 87 | 111 | $94,350 | $17,024 | 18.0% |
About Dr. Gary Gelbfish, M.D
Dr. Gary Gelbfish, M.D is a Vascular Surgery healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275508954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gelbfish, M.D has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $1.9M received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Acquisitions" ($1.9M).
As a Medicare-enrolled provider, Gelbfish has provided services to 14,376 Medicare beneficiaries, totaling 34,754 services with total Medicare billing of $7.1M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular Surgery
- Location Brooklyn, NY
- Active Since 02/17/2006
- Last Updated 07/03/2008
- Taxonomy Code 2086S0129X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275508954
Products in Payments
- GENERAL ULTRASOUND (Device) $46.29
- JARDIANCE (Drug) $26.91
- Chameleon (Device) $19.83
- Clot Management (Device) $17.00
- ROTATEQ (Biological) $16.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular Surgery Doctors in Brooklyn
Dr. Robert Rhee, Md, MD
Vascular Surgery — Payments: $390,493
Vascular Surgery $390,493
William Lois, M.d, M.D
Vascular Surgery — Payments: $77,563
Vascular Surgery $77,563
Nicole Ilonzo
Vascular Surgery — Payments: $64,059
Vascular Surgery $64,059
Enrico Ascher, Md, MD
Vascular Surgery — Payments: $60,178
Vascular Surgery $60,178
Dr. Michael Shapiro, Md, MD
Vascular Surgery — Payments: $43,281
Vascular Surgery $43,281
Anil Hingorani, Md, MD
Vascular Surgery — Payments: $17,616
Vascular Surgery $17,616